Advances in Cancer Immunotherapy™ (ACI) Series

ACI programs are certified for CME, CNE, CPE, and MOC credits. ACI's offer in-depth clinical training in immunotherapy treatment for a variety of disease states and topics. ACI webinars are FREE for healthcare professionals, students, patients and patient advocates.

Advances in Cancer Immunotherapy™: A Focus on Intratumoral Therapies, Vaccines, & Cytokines

Wednesday, Oct. 9 | 11 a.m.–3 p.m. ET Virtual – Zoom

Program features a session on emerging therapies, where the EMERALD trial and FLASH radiotherapy plan to be discussed. 

Rationalized Patient Match and Clinical Trial Design with Large/Moderate Language Models on EHR Data: AI in IO Webinar

Tuesday, Oct. 15 | 1–2 p.m. ET | Virtual

Learn how advances in AI application are used to analyze EHR data to better design immunotherapy clinical trials and efficiently match potential patients.

Monitoring Response to Immunotherapy (iRECIST): Increasing Access to IO Webinar

Wednesday, Oct. 16 | 12–1:30 p.m. EDT

This webinar will examine the importance of assessing tumor response to immunotherapy with currently available tools, primarily iRECIST, and how they compare to RECIST and WHO criteria.

Targets for Cancer IO: A Deep Dive into the Role of Neutrophils in Anti-tumor Immunity Webinar

Wed., Oct. 23 | 12–2 p.m. ET | Virtual

Leading experts in the field will provide an overview of the current state of the science and address questions about its future. An interactive Q&A session will follow the topic overview of this webinar.

.

Advances in Cancer Immunotherapy™: A Focus on Pathology

Tuesday, Dec. 10 |11 a.m.–3 p.m. ET Virtual – Zoom

Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of the clinical implementation of immuno-oncology pathology.

2025 Cancer Immunotherapy Winter School

February 11–14, 2025 in Austin, TX
and Virtually

Explore the core principles of tumor immunology and cancer immunotherapy, including biomarker technology, validation and clinical integration, clinical trial design, data analysis and considerations for combination therapies.

SITC Sparkathon Class of 2025: Cellular Therapy for Solid Tumors

March 10–12, 2025 in San Diego, CA

This impactful program brings together early career investigators with established leaders in cancer immunotherapy to foster leadership development, collaborations and scientific exchange

2025 Spring Scientific: Cellular Therapy for Solid Tumors

March 12–14, 2025 in San Diego, CA
& Virtually

SITC will bring the brightest minds and the next generation of leaders together to explore promising science and develop novel opportunities to challenges that impede bringing these novel therapies to patients in need.